Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
07/17/1991 | EP0436851A1 Compounds active as inhibitors of the enzyme HMG-CoA reductase and pharmaceutical compositions containing them |
07/17/1991 | CN1053062A Vitamin e derivatives and process for preparing them |
07/17/1991 | CA2034206A1 Di(nitroxyalkyl)amides of pyridine-2,4- and -2,5-dicarboxylic acids, a process for the preparation thereof, and the use thereof |
07/16/1991 | US5032602 Inhibiting HMG-CoA reductase with novel substituted 2-pyridones and pyrid-2-thiones |
07/16/1991 | US5032590 Substituted hydroxylamines |
07/16/1991 | US5032583 Cardiovascular disorders |
07/16/1991 | CA1286304C Substituted azetidinones as anti-inflammatory and antidegenerative agents |
07/16/1991 | CA1286300C 5-(1-cyano-n-methyl-n-phenethyl)-alkylamino-2,2-8-trimethyl -4h-dioxino-¬4,5-c|-pyridine derivatives |
07/13/1991 | WO1991010662A1 2-substituted 4,5-diphenyl-imidazoles |
07/13/1991 | WO1991010646A1 1-azetidyl and 1-hexamethylenimine alkyl or aryl bisphosphonic acids and their use as pharmacological agents |
07/13/1991 | CA2073448A1 1-azetidyl and 1-hexamethylenimine alkyl of aryl bisphosphonic acids and their use as pharmacological agents |
07/13/1991 | CA2073443A1 2-substituted 4,5-diphenyl-imidazoles |
07/12/1991 | CA2033928A1 Compositions and methods for inhibiting osteoclast cellular adhesion to bone |
07/11/1991 | WO1991009841A1 Novel vitamin d analogues |
07/11/1991 | WO1991009619A1 Pharmaceutical compositions containing antigen-antibody complexes and uses therefor |
07/11/1991 | WO1991009617A1 Insulin preparations containing nicotinic acid or nicotinamide |
07/11/1991 | WO1991009604A1 A pharmaceutical composition comprising a phosphosugar |
07/11/1991 | WO1991009603A1 Ganglioside derivatives and their use as medicaments |
07/11/1991 | CA2070814A1 Insulin preparations containing nicotinic acid or nicotinamide |
07/10/1991 | WO1991010436A1 Salt eliminant composition |
07/10/1991 | WO1991010429A1 Lipid absorption inhibiting composition |
07/10/1991 | WO1991010371A1 Acat enzyme inhibiting composition |
07/10/1991 | EP0436469A1 Composition and method for the treatment of osteoporosis in mammals |
07/10/1991 | EP0436307A1 Substituted oxophthalazinyl acetic acids and analogs thereof |
07/10/1991 | CA2048614A1 Salt excretion-promoting composition |
07/09/1991 | US5030772 Condensation of steroidal aldehyde with arylsulfone, reduction of formed adduct with amalgam, followed by conversion to desired vitamin D |
07/09/1991 | US5030640 Novel β-adrenergic agonists and pharmaceutical compositions thereof |
07/09/1991 | US5030630 Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine- for treating diseases caused by reduced secretion of growth hormone |
07/09/1991 | US5030626 Fluorine derivatives of vitamin D3 and process for producing the same |
07/06/1991 | CA2033649A1 Vitamin e derivatives and process for the production thereof |
07/03/1991 | EP0435362A1 Composition comprising non-steroidal anti-inflammatory agent and effectively non-antibacterial tetracycline |
07/03/1991 | EP0434844A1 New cyclic anthranilic acid derivative and method of producing the same |
07/03/1991 | CN1052674A Heterocyclic chemistry |
07/02/1991 | US5028730 Antihypercholesterolemic nitrile compounds |
07/02/1991 | US5028711 Hypotensive Agents |
07/02/1991 | US5028617 Livestock, controlling obesity in humans |
07/02/1991 | US5028614 Hydroxymethyl-indolizidines and quinolizidines and their use as α-glucosidase I inhibitors |
07/02/1991 | US5028587 Containing arg-b31 and/or arg2-(b31-32) human insulin; antidiabetic agents |
07/02/1991 | CA1285562C Quinone derivatives, their production and use |
07/02/1991 | CA1285491C Method of treating catabolic dysfunction |
07/02/1991 | CA1285423C Method for increasing the feed intake of an animal |
06/27/1991 | WO1991009019A1 Substituted oxophthalazinyl acetic acids and analogs thereof |
06/27/1991 | WO1991009017A1 Quinoline derivatives, their production and use |
06/27/1991 | WO1991001963A3 Use of sebacic acid and derivatives thereof in enteral and parenteral nutrition and pharmaceutical compositions containing said compounds |
06/26/1991 | EP0434621A2 Rifamycin derivatives and processes for the manufacture thereof |
06/26/1991 | EP0434405A1 Imidazo[4,5-c]pyridines as antiosteoporotic agents |
06/26/1991 | EP0434360A1 New benziodiazepine analogs |
06/26/1991 | EP0434088A1 Pharmaceutical compositions containing L-carnitine |
06/26/1991 | EP0433978A2 New process for the preparation of nojirimycin and related compounds |
06/26/1991 | EP0433842A2 1,2,3-Triazole derivatives active as inhibitors of the enzyme HMG-COA reductase and pharmaceutical compositions containing them |
06/26/1991 | EP0433679A2 Pharmaceutical compositions for inhibition of maillard's reaction |
06/26/1991 | EP0433662A2 Acat inhibitors |
06/26/1991 | EP0433402A1 Therapeutic compounds, compositions and uses thereof |
06/26/1991 | EP0433390A1 Swine growth promotion |
06/25/1991 | US5026882 Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase |
06/25/1991 | US5026858 Used for treating nausea, vomating, gastrointestinal disorders and centarl nervous system |
06/25/1991 | US5026825 With aminolevulinic acid |
06/25/1991 | US5026714 Novel 1-alkyl-substituted 1,4-dihydropyridinelactone anti-diabetics |
06/25/1991 | US5026555 Coating anticholesterol particles with lecithin, and mixing with a sweetened partially-set water, gelatin and glycerin mixture and flavors |
06/25/1991 | CA1285280C Quinone derivatives, their production and use |
06/25/1991 | CA1285227C Long lasting dihydropyridine calcium channel blockers |
06/22/1991 | CA2032672A1 Rifamycin derivatives and processes for the manufacture thereof |
06/22/1991 | CA2032445A1 Imidazo[4,5-c]pyridines as antiosteoporotic agents |
06/21/1991 | WO1991009048A1 Boronated nucleosides |
06/21/1991 | CA2071936A1 Boronated nucleosides |
06/19/1991 | WO1991009044A1 Novel 1-triacontanol derivatives |
06/19/1991 | WO1991009032A1 Piperidine compounds and a pharmaceutical composition |
06/19/1991 | EP0433167A1 Piperidine derivates, process for their preparation and pharmaceutical compositions containing them |
06/19/1991 | EP0432479A1 Anhydrous pharmaceutical formulations and dosage forms for the rectal administration of calcitonin |
06/19/1991 | EP0432442A1 ACAT inhibitors |
06/19/1991 | CA2071480A1 Piperidine compounds and a pharmaceutical composition |
06/19/1991 | CA2047246A1 1-triacontanol derivatives |
06/19/1991 | CA2032427A1 Benzodiazepines analogs |
06/18/1991 | US5025017 Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates |
06/18/1991 | US5025011 Calcium-antigonist and beta-blocking properties; antihypertensives; vasodilators |
06/18/1991 | US5025010 Benzothiazinone derivatives, and pharmaceuticals containing them |
06/18/1991 | US5025003 Isoprenoid phosphinylformic acid squalene synthetase inhibitors |
06/18/1991 | US5025000 Phosphorus-containing HMG-CoA reductase inhibitor compounds |
06/18/1991 | US5024731 Method of manufacturing material for medical and pharmaceutical products from pyroligneous acid |
06/13/1991 | WO1991009030A1 2-substituted 4,5-diphenyl-imidazoles |
06/13/1991 | WO1991008225A1 Hexapeptides with sulphate ester groups |
06/13/1991 | CA2071497A1 2-substituted 4,5-diphenyl-imidazoles |
06/13/1991 | CA2031839A1 Piperidine derivatives, preparation thereof and pharmaceutical compositions containing the same |
06/12/1991 | WO1991009024A1 Quinazoline-3-alkanoic acid derivative, salt thereof, and production thereof |
06/12/1991 | WO1991009021A1 Imidazoles |
06/12/1991 | WO1991008679A1 Functional food |
06/12/1991 | EP0432040A1 Heterocyclic derivatives of acylaminothiazole, their preparation and pharmaceutical compositions containing them |
06/12/1991 | EP0431943A2 Nitrogen-containing spirocycles |
06/12/1991 | EP0431763A2 Therapeutic agents for lowering triglyceride and/or cholesterol levels and/or increasing HDL levels |
06/12/1991 | EP0431519A1 System for transdermal albuterol administration |
06/12/1991 | EP0431480A2 Substituted 10-ring-lactones, process for their preparation and their use |
06/12/1991 | EP0431321A1 Acat inhibitors |
06/12/1991 | CA2071498A1 Imidazoles |
06/12/1991 | CA2046603A1 Quinazoline-3-alkanoic acid derivatives, their salts and their preparation processes |
06/11/1991 | US5023358 Vanadyl organo-mineral compound, method for obtaining such a compound, pharmaceutical composition containing this organo-mineral compound |
06/09/1991 | CA2031633A1 Nitrogen-containing spirocycles |
06/08/1991 | WO1991009006A1 New bicyclic amino-substituted compounds |
06/08/1991 | CA2046292A1 Bicyclic amino-substituted compounds |
06/06/1991 | WO1991007978A1 Synthetic calcitonin peptides |
06/06/1991 | CA2069943A1 Synthetic calcitonin peptides |